No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Aquilion Exceed LB CT System Received FDA Clearance

Editor: What To Know

  • Expanded capabilities – the Aquilion Exceed LB is also uniquely designed to meet the needs of radiology departments requiring the flexibility to handle bariatric patients and challenging patient positioning, and with patient access and technology designed to streamline CT interventions.
  • The Aquilion Exceed LB system supports fast and efficient radiation oncology workflows without compromising on patient position, image quality, or reproducibility.
  • Aquilion Exceed LB CT system gives clinicians the opportunity to see more during radiation therapy planning for accuracy, precision, and speed.

January 21, 2021

Aquilion Exceed LB CT system gives clinicians the opportunity to see more during radiation therapy planning for accuracy, precision, and speed.

As cancer cases continue to increase in the U.S., providing clinicians with the latest technology for accurate simulation across treatment plans remains critical.

The Aquilion Exceed LB system supports fast and efficient radiation oncology workflows without compromising on patient position, image quality, or reproducibility. Features include:

  • Accuracy even in complex simulations through industry-leading capabilities, like the largest bore opening (90 cm), edge-to-edge extended Field-of-View (90 cm) reconstruction and wide detector coverage (4 cm).
  • Better contouring powered by Artificial Intelligence (AI) with sharp, clear and distinct images from Canon Medical’s Advanced intelligent Clear-IQ Engine (AiCE) Deep Learning Reconstruction (DLR) technology.
  • Expanded capabilities – the Aquilion Exceed LB is also uniquely designed to meet the needs of radiology departments requiring the flexibility to handle bariatric patients and challenging patient positioning, and with patient access and technology designed to streamline CT interventions.

“The Aquilion Exceed LB system was designed to push the boundaries of traditional simulation,” said Erin Angel, managing director, CT Business Unit, Canon Medical Systems USA, Inc. “Deep learning reconstruction will give radiation oncology teams the confidence they need for accurate and precise planning across patients.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy